Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9415710rdf:typepubmed:Citationlld:pubmed
pubmed-article:9415710lifeskim:mentionsumls-concept:C0027713lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C0205107lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C0678640lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C0597484lld:lifeskim
pubmed-article:9415710lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:9415710pubmed:issue6lld:pubmed
pubmed-article:9415710pubmed:dateCreated1998-1-29lld:pubmed
pubmed-article:9415710pubmed:abstractTextActivation of alpha 1-adrenergic receptors (alpha 1-AR) increases Na+/H+ exchange (NHE) in proximal tubule. NHE mediates the majority of active Na+ absorption in the proximal tubule. Three alpha 1-AR subtypes have been detected in kidney by molecular and binding techniques. We detected message for all three alpha 1-AR subtypes in mouse proximal tubule cells through reverse transcription-polymerase chain reaction and Northern analysis. To determine the alpha 1-AR subtypes that regulate NHE in mouse proximal tubule cells, two strategies were used: (i) antisense oligodeoxynucleotides (ODNs) to selectively inhibit expression of alpha 1A-, alpha 1B-, and alpha 1D-AR subtypes and (ii) subtype-selective alpha 1-AR antagonists. Streptolysin-O permeabilization was used to introduce antisense and sense ODNs into cells three times over 72 hr. Western blot analysis of membranes prepared from cells treated with alpha 1B-AR antisense ODN demonstrated that alpha 1B-AR protein expression was reduced by 90% at 72 hr compared with control or sense ODN treatments. Functional regulation of NHE by alpha 1-ARs was determined by alpha 1-AR agonist changes in intracellular pH (pHi) in cells grown on coverslips and loaded with 2',7'-bis(2-carboxyethyl)-5(6)carboxyfluorescein-acetoxymethyl ester. Antisense ODNs for alpha 1B-AR significantly reduced phenylephrine (PHE)-induced maximal changes in pHi by 49%. The PHE-induced changes in pHi observed in cells treated with alpha 1A-AR antisense ODNs was reduced by 42%. The selective alpha 1A-AR antagonist WB-4101 and the alpha 1B-AR antagonist spiperone reduce PHE-induced pHi increases to a comparable extent. No significant changes in pHi were observed with cells treated with alpha 1D-AR antisense ODNs or the alpha 1D-AR antagonist BMY 7378 compared with untreated cells. Combined treatment with alpha 1A- and alpha 1B-AR antisense ODNs and antagonists additively inhibits PHE-induced delta pHi by 90%. We conclude that alpha 1A and alpha 1B-AR but not alpha 1D-ARs regulate NHE in proximal tubule cells.lld:pubmed
pubmed-article:9415710pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:languageenglld:pubmed
pubmed-article:9415710pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:citationSubsetIMlld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9415710pubmed:statusMEDLINElld:pubmed
pubmed-article:9415710pubmed:monthDeclld:pubmed
pubmed-article:9415710pubmed:issn0026-895Xlld:pubmed
pubmed-article:9415710pubmed:authorpubmed-author:FriedmanP APAlld:pubmed
pubmed-article:9415710pubmed:authorpubmed-author:LisHHlld:pubmed
pubmed-article:9415710pubmed:authorpubmed-author:DreznerM KMKlld:pubmed
pubmed-article:9415710pubmed:authorpubmed-author:NesbittTTlld:pubmed
pubmed-article:9415710pubmed:authorpubmed-author:GesekF AFAlld:pubmed
pubmed-article:9415710pubmed:issnTypePrintlld:pubmed
pubmed-article:9415710pubmed:volume52lld:pubmed
pubmed-article:9415710pubmed:ownerNLMlld:pubmed
pubmed-article:9415710pubmed:authorsCompleteYlld:pubmed
pubmed-article:9415710pubmed:pagination1010-8lld:pubmed
pubmed-article:9415710pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:meshHeadingpubmed-meshheading:9415710-...lld:pubmed
pubmed-article:9415710pubmed:year1997lld:pubmed
pubmed-article:9415710pubmed:articleTitleProximal nephron Na+/H+ exchange is regulated by alpha 1A- and alpha 1B-adrenergic receptor subtypes.lld:pubmed
pubmed-article:9415710pubmed:affiliationDepartment of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.lld:pubmed
pubmed-article:9415710pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9415710pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9415710lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9415710lld:pubmed